Publication
Visualizing eligibility gaps between muscle-invasive bladder cancer trials and real-world patients.
Takaki Ichiyama, Takuma Narita, Yuya Sekine, Masanao Shinohara, Yohei Kawashima, Mizuki Kobayashi, Kazuyuki Numakura, Jotaro Mikami, Naoki Fujita, Teppei Okamoto, Hayato Yamamoto, Shintaro Narita, Satoshi Sato, Tomonori Habuchi, Chikara Ohyama, Shingo Hatakeyama
- Source
- PubMed
- Retrieved
- Sep 18, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-PUBMED-20260918-000001
Abstract
Abstract (excerpt)
Only the opening of the abstract is shown; abstract text may carry publisher copyright.
OBJECTIVES: Clinical studies in muscle-invasive bladder cancer (MIBC) often enroll younger and fitter patients than those treated in routine practice, limiting generalizability. We developed a simple eligibility gap (EG) score to quantify baseline eligibility differences between clinical studies…
Read on PubMedLinked entities
Linked entities (1)
How each link was made (MeSH, dictionary, registry reference, curation…) and whether it has been validated. Candidate links are not counted in entity statistics.
Candidate 1
- cancerMalignant Bladder Neoplasmdictionary0.60
Curated evidence
Evidence citing this paper (0)
Data not yet available